IOTA NanoSolutions strengthens its Board through appointment of Dr Julian Gilbert as Non-Executive Director
Advertisement
The Board of IOTA NanoSolutions announced the appointment of Dr Julian Gilbert as Non-Executive Director of the company.
Dr. Gilbert brings over 20 years of commercial and technical experience in the pharmaceutical industry to the role having previously held positions at SmithKline & French, BTG, Mundipharma and Chiroscience. Currently Dr Gilbert is co-founder and CEO of Acacia Pharma, a pharmaceutical company focused on the development and commercialisation of product opportunities for cancer supportive care. Prior to this, he was co-founder and Commercial Director of Arakis, a low risk discovery and development company. Arakis successfully raised £49m in private equity and developed a pipeline of five clinical phase opportunities. Its most advanced product opportunities were out-licensed to Novartis (AD 237 for COPD) and Mundipharma (AD 923 for cancer breakthrough pain). Arakis was sold to Sosei in 2005 for £106m.